Literature DB >> 12585658

Contrast agents and temporal resolution in breast MR imaging.

F Sardanelli1, A Iozzelli, A Fausto.   

Abstract

The article summarizes the technique of dynamic Gd-enhanced breast magnetic resonance (MR) imaging and the established clinical indications to this examination. The main features of the four different non-selective Gd-chelates today available for contrast-enhanced MR breast imaging are described. Their typical two-compartment (vascular/interstitial) distribution is related to the temporal resolution used for the MR acquisition; the gain in specificity obtained increasing the temporal resolution during the first phase after the contrast intravenous injection (using both, rapid T1-weighted sequences or ultrafast T2*-weighted perfusion imaging) is discussed. Moreover, a survey of new contrast agents is supplied, including a high T1-relaxivity Gd-chelate, blood pool agents, and lymph node targeted agents. In conclusion, future directions are delineated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12585658

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  3 in total

1.  Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise.

Authors:  Toni W Vomweg; Andrea Teifke; R Peter Kunz; Christian Hintze; Alexander Hlawatsch; Annett Kern; Karl F Kreitner; Manfred Thelen
Journal:  Eur Radiol       Date:  2004-07-29       Impact factor: 5.315

2.  Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet.

Authors:  M Calabrese; D Brizzi; L Carbonaro; M Chiaramondia; M A Kirchin; F Sardanelli
Journal:  Radiol Med       Date:  2009-02-04       Impact factor: 3.469

Review 3.  MR imaging of the breast: indications, established technique, and new directions.

Authors:  F Sardanelli; A Iozzelli; A Fausto
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 7.034

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.